Korenberg Matthew E
Insider CIK 1649903 · LFCR Director · QLGN Director · PVLA CFO, Treasurer · LGND VP, Finance and CFO
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| PVLA PALVELLA THERAPEUTICS, INC | M Exercise deriv | 2026-06-12 | 2026-06-16 | 1,000 | — | $0 | 166,100 | SEC↗ |
| PVLA PALVELLA THERAPEUTICS, INC | M Exercise | 2026-06-12 | 2026-06-16 | 1,000 | $13.60 | $13.6K | 1,000 | SEC↗ |
| LFCR LIFECORE BIOMEDICAL, INC. | A Award | 2026-06-04 | 2026-06-05 | 25,907 | — | $0 | 69,967 | SEC↗ |
| PVLA PALVELLA THERAPEUTICS, INC | A Award deriv | 2026-02-05 | 2026-02-09 | 44,123 | — | $0 | 44,123 | SEC↗ |
| LFCR LIFECORE BIOMEDICAL, INC. | A Award | 2025-07-15 | 2025-07-17 | 19,506 | — | $0 | 44,060 | SEC↗ |
| PVLA PALVELLA THERAPEUTICS, INC | A Award deriv | 2025-02-05 | 2025-02-10 | 123,559 | — | $0 | 123,559 | SEC↗ |
| PVLA PALVELLA THERAPEUTICS, INC | A Award deriv | 2025-02-05 | 2025-02-10 | 5,373 | — | $0 | 5,373 | SEC↗ |
| PVLA PALVELLA THERAPEUTICS, INC | A Award deriv | 2024-12-13 | 2024-12-17 | 167,100 | — | $0 | 167,100 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise deriv | 2024-09-23 | 2024-09-24 | 9,377 | — | $0 | 42,436 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise deriv | 2024-09-23 | 2024-09-24 | 395 | — | $0 | 0 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | S Sale | 2024-09-23 | 2024-09-24 | 7,090 | $101.61 | $720.4K | 50,978 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | S Sale | 2024-09-23 | 2024-09-24 | 2,481 | $100.05 | $248.2K | 58,068 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | S Sale | 2024-09-23 | 2024-09-24 | 201 | $102.05 | $20.5K | 50,777 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise | 2024-09-23 | 2024-09-24 | 9,377 | $52.84 | $495.5K | 60,549 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise | 2024-09-23 | 2024-09-24 | 395 | $49.99 | $19.7K | 51,172 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise deriv | 2024-09-20 | 2024-09-24 | 4,982 | — | $0 | 395 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | S Sale | 2024-09-20 | 2024-09-24 | 6,275 | $104.10 | $653.2K | 50,777 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise | 2024-09-20 | 2024-09-24 | 4,982 | $49.99 | $249.1K | 57,052 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise deriv | 2024-09-16 | 2024-09-18 | 914 | — | $0 | 25,949 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise deriv | 2024-09-16 | 2024-09-18 | 671 | — | $0 | 5,377 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise deriv | 2024-09-16 | 2024-09-18 | 849 | — | $0 | 12,452 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise deriv | 2024-09-16 | 2024-09-18 | 3,340 | — | $0 | 18,500 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | F Tax w/h | 2024-09-16 | 2024-09-18 | 485 | $105.00 | $50.9K | 49,939 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | F Tax w/h | 2024-09-16 | 2024-09-18 | 472 | $105.00 | $49.6K | 50,316 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise | 2024-09-16 | 2024-09-18 | 671 | $49.99 | $33.5K | 50,987 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | F Tax w/h | 2024-09-16 | 2024-09-18 | 1,938 | $105.00 | $203.5K | 52,070 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | F Tax w/h | 2024-09-16 | 2024-09-18 | 319 | $105.00 | $33.5K | 50,668 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise | 2024-09-16 | 2024-09-18 | 3,340 | $60.94 | $203.5K | 54,008 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise | 2024-09-16 | 2024-09-18 | 914 | $55.75 | $51.0K | 50,424 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise | 2024-09-16 | 2024-09-18 | 849 | $58.49 | $49.7K | 50,788 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | S Sale | 2024-08-26 | 2024-08-26 | 5,212 | $106.32 | $554.1K | 49,510 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | S Sale | 2024-08-26 | 2024-08-26 | 6,177 | $105.02 | $648.7K | 54,722 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | S Sale | 2024-08-23 | 2024-08-26 | 2,037 | $104.09 | $212.0K | 65,174 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | S Sale | 2024-08-23 | 2024-08-26 | 4,275 | $105.13 | $449.4K | 60,899 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | S Sale | 2024-08-22 | 2024-08-26 | 1,157 | $105.54 | $122.1K | 67,211 | SEC↗ |
| LFCR LIFECORE BIOMEDICAL, INC. | A Award | 2024-08-19 | 2024-08-21 | 24,554 | — | $0 | 24,554 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | S Sale | 2024-08-09 | 2024-08-13 | 18,245 | $98.50 | $1.80M | 68,368 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | J Other | 2024-06-28 | 2024-07-02 | 350 | $60.71 | $21.2K | 86,613 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | S Sale | 2024-05-14 | 2024-05-15 | 13,638 | $85.08 | $1.16M | 86,783 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | S Sale | 2024-05-14 | 2024-05-15 | 520 | $85.68 | $44.6K | 86,263 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | S Sale | 2024-05-13 | 2024-05-15 | 3,440 | $84.54 | $290.8K | 100,421 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | A Award deriv | 2024-02-27 | 2024-02-29 | 58,544 | — | $0 | 58,544 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | A Award | 2024-02-27 | 2024-02-29 | 14,416 | — | $0 | 103,861 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | F Tax w/h | 2024-02-15 | 2024-02-16 | 4,778 | $74.65 | $356.7K | 89,445 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | F Tax w/h | 2024-01-02 | 2024-01-04 | 2,917 | $72.31 | $210.9K | 94,223 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | F Tax w/h | 2023-12-05 | 2023-12-06 | 1,984 | $59.61 | $118.3K | 97,140 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | J Other | 2023-06-30 | 2023-07-10 | 376 | $56.78 | $21.3K | 99,124 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | A Award deriv | 2023-02-23 | 2023-02-27 | 24,628 | — | $0 | 24,628 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | A Award | 2023-02-23 | 2023-02-27 | 9,069 | — | $0 | 98,748 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | F Tax w/h | 2023-02-15 | 2023-02-17 | 2,890 | $72.98 | $210.9K | 89,679 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | F Tax w/h | 2022-12-28 | 2022-12-30 | 3,859 | $66.29 | $255.8K | 92,569 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | A Award deriv | 2022-12-22 | 2022-12-27 | 25,967 | — | $0 | 25,967 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | A Award deriv | 2022-12-13 | 2022-12-15 | 30,000 | — | $0 | 30,000 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | A Award | 2022-12-13 | 2022-12-15 | 14,000 | — | $0 | 96,428 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | F Tax w/h | 2022-11-30 | 2022-12-01 | 3,593 | $72.90 | $261.9K | 82,428 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | A Award | 2022-11-01 | 2022-11-03 | 27,714 | — | $0 | 86,021 | SEC↗ |
| QLGN Qualigen Therapeutics, Inc | A Award deriv | 2022-07-11 | 2022-08-04 | 40,000 | — | $0 | 40,000 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | J Other | 2022-06-30 | 2022-07-06 | 164 | $75.84 | $12.4K | 52,532 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | A Award | 2022-06-10 | 2022-06-14 | 8,062 | — | $0 | 52,368 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | A Award deriv | 2022-05-05 | 2022-05-09 | 30,189 | — | $0 | 30,189 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | F Tax w/h | 2022-02-15 | 2022-02-16 | 906 | $123.68 | $112.1K | 46,807 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | F Tax w/h | 2022-02-15 | 2022-02-16 | 969 | $123.68 | $119.8K | 45,838 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | F Tax w/h | 2022-02-15 | 2022-02-16 | 1,532 | $123.68 | $189.5K | 44,306 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | F Tax w/h | 2022-01-26 | 2022-01-28 | 2,309 | $113.68 | $262.5K | 47,713 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | F Tax w/h | 2022-01-26 | 2022-01-28 | 1,319 | $113.68 | $149.9K | 50,022 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | A Award | 2022-01-26 | 2022-01-28 | 6,848 | — | $0 | 51,341 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | A Award | 2022-01-26 | 2022-01-28 | 4,803 | — | $0 | 44,493 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | J Other | 2021-06-30 | 2021-07-02 | 247 | $85.91 | $21.2K | 39,690 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | F Tax w/h | 2021-02-15 | 2021-02-18 | 434 | $172.46 | $74.8K | 41,318 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | F Tax w/h | 2021-02-15 | 2021-02-18 | 906 | $172.46 | $156.2K | 40,412 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | F Tax w/h | 2021-02-15 | 2021-02-18 | 969 | $172.46 | $167.1K | 39,443 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | A Award deriv | 2021-02-03 | 2021-02-05 | 11,591 | — | $0 | 11,591 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | A Award | 2021-02-03 | 2021-02-05 | 10,819 | — | $0 | 41,752 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | F Tax w/h | 2021-01-25 | 2021-01-27 | 671 | $156.01 | $104.7K | 27,570 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | A Award | 2021-01-25 | 2021-01-27 | 4,803 | — | $0 | 32,373 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | F Tax w/h | 2021-01-25 | 2021-01-27 | 1,440 | $156.01 | $224.7K | 30,933 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | A Award | 2021-01-25 | 2021-01-27 | 2,305 | — | $0 | 28,241 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | J Other | 2020-06-30 | 2020-07-01 | 238 | $89.03 | $21.2K | 25,936 | SEC↗ |
| QLGN Qualigen Therapeutics, Inc | A Award deriv | 2020-06-06 | 2020-06-08 | 50,000 | — | $0 | 50,000 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | A Award deriv | 2020-02-13 | 2020-02-18 | 30,750 | — | $0 | 30,750 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | A Award | 2020-02-13 | 2020-02-18 | 6,848 | — | $0 | 26,864 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | A Award | 2019-12-20 | 2019-12-26 | 2,674 | — | $0 | 19,825 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | F Tax w/h | 2019-12-20 | 2019-12-26 | 1,135 | $105.87 | $120.2K | 18,690 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | A Award | 2019-12-20 | 2019-12-26 | 2,305 | — | $0 | 20,995 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | F Tax w/h | 2019-12-20 | 2019-12-26 | 979 | $105.87 | $103.6K | 20,016 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | P Buy deriv | 2019-09-19 | 2019-09-23 | 0 | $989937.50 | $0 | 0 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | P Buy | 2019-09-03 | 2019-09-03 | 500 | $86.18 | $43.1K | 17,151 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | J Other | 2019-06-28 | 2019-07-02 | 182 | $97.03 | $17.7K | 16,651 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | F Tax w/h | 2019-02-15 | 2020-04-24 | 354 | $120.86 | $42.8K | 16,115 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | F Tax w/h | 2019-02-15 | 2020-04-24 | 377 | $120.86 | $45.6K | 15,738 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | F Tax w/h | 2019-02-15 | 2020-04-24 | 435 | $120.86 | $52.6K | 15,303 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | A Award deriv | 2019-02-11 | 2019-02-13 | 29,298 | — | $0 | 29,298 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | A Award | 2019-02-11 | 2019-02-13 | 6,404 | — | $0 | 16,469 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | F Tax w/h | 2019-01-23 | 2019-01-25 | 713 | $111.78 | $79.7K | 8,447 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | A Award | 2019-01-23 | 2019-01-25 | 2,230 | — | $0 | 10,677 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | F Tax w/h | 2019-01-23 | 2019-01-25 | 612 | $111.78 | $68.4K | 10,065 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | A Award | 2019-01-23 | 2019-01-25 | 2,418 | — | $0 | 9,160 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise deriv | 2018-08-29 | 2018-08-29 | 11,540 | — | $0 | 6,924 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | S Sale | 2018-08-29 | 2018-08-29 | 18,357 | $256.69 | $4.71M | 6,742 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise | 2018-08-29 | 2018-08-29 | 11,540 | $85.79 | $990.0K | 25,099 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | F Tax w/h | 2018-08-06 | 2018-08-07 | 836 | $226.74 | $189.6K | 13,559 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | J Other | 2018-06-29 | 2018-07-03 | 180 | $117.84 | $21.2K | 14,395 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | A Award | 2018-03-06 | 2018-03-06 | 2,004 | — | $0 | 14,765 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | F Tax w/h | 2018-03-06 | 2018-03-06 | 550 | $165.87 | $91.2K | 14,215 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | A Award deriv | 2018-03-02 | 2018-03-06 | 16,050 | — | $0 | 16,050 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | A Award | 2018-03-02 | 2018-03-06 | 3,074 | — | $0 | 12,761 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | F Tax w/h | 2018-02-15 | 2018-02-16 | 354 | $157.18 | $55.6K | 10,013 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | F Tax w/h | 2018-02-15 | 2018-02-16 | 326 | $157.18 | $51.2K | 9,687 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | A Award | 2017-12-28 | 2017-12-29 | 3,750 | — | $0 | 11,897 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | F Tax w/h | 2017-12-28 | 2017-12-29 | 1,530 | $138.66 | $212.1K | 10,367 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | S Sale | 2017-11-17 | 2017-11-17 | 6,559 | $142.63 | $935.5K | 8,147 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | F Tax w/h | 2017-08-06 | 2017-08-08 | 609 | $122.06 | $74.3K | 14,706 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | J Other | 2017-06-30 | 2017-07-05 | 243 | $87.13 | $21.2K | 15,315 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | A Award deriv | 2017-02-24 | 2017-02-28 | 15,225 | — | $0 | 15,225 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | A Award | 2017-02-24 | 2017-02-28 | 3,567 | — | $0 | 15,072 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | A Award | 2017-02-24 | 2017-02-28 | 3,450 | — | $0 | 12,556 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | F Tax w/h | 2017-02-24 | 2017-02-28 | 1,051 | $100.38 | $105.5K | 11,505 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | F Tax w/h | 2017-02-15 | 2017-02-28 | 391 | $104.28 | $40.8K | 9,106 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | J Other | 2016-12-30 | 2017-01-03 | 40 | $86.37 | $3.5K | 10,106 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | F Tax w/h | 2016-08-06 | 2017-02-28 | 609 | $123.30 | $75.1K | 9,457 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | J Other | 2016-06-30 | 2016-07-05 | 196 | $87.10 | $17.1K | 10,066 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | A Award deriv | 2016-02-11 | 2016-02-16 | 18,464 | — | $0 | 18,464 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | A Award | 2016-02-11 | 2016-02-16 | 3,870 | — | $0 | 9,870 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | A Award deriv | 2015-08-06 | 2015-08-07 | 25,000 | — | $0 | 25,000 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | A Award | 2015-08-06 | 2015-08-07 | 6,000 | — | $0 | 6,000 | SEC↗ |